Reversing the Healthcare Cascade
For decades, the healthcare industry has been entrenched in a top-down paradigm. From researchers to physicians and then, as an afterthought, to the patients, information trickles down, often losing its efficacy and personal touch along the way.
Yet, what if the cascade were reversed? What if the source of information and the driving force behind outreach were the very patients these trials aim to serve?
The Grassroots Approach
Enter the grassroots approach: a patient-led, bottom-up strategy that seeks to tap into the rich and often overlooked wellspring of community connections. This method is rooted in a simple but powerful truth:
People trust those they know. It's not just about receiving information but about understanding, believing, and acting upon it.
Steering Clinical Trials Toward Greater Diversity
Traditional outreach methods, rooted in top-down approaches, have inadvertently resulted in a stark racial and economic disparity in clinical trial participation. Despite progress, underrepresented communities still face barriers rooted in history and mistrust.
Clinical trials are the heartbeat of medical advancements, yet their effectiveness is compromised when diverse voices are left out.
Our Response
In response to the urgent need for greater diversity in clinical trials, WeHealth champions a patient-led, grassroots strategy, aligning seamlessly with the FDA's call for change. We believe that by empowering patients to become advocates within their own communities, we can break down the barriers that have long prevented equitable participation in clinical research.